FDA approves Leqembi, new treatment for early-stage Alzheimer’s
Researchers Chase Biomarkers – Potential Keys to Long COVID
January 6, 2023
What you should know about the newly approved Alzheimer’s drug
January 6, 2023 [ad_1]
The drug Leqembi may slightly slow cognitive decline in the early stages of the disease, but it comes with some safety risks. However, data suggests it holds more promise than the small number of other treatments available.
[ad_2]
Source link
